BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1246 related articles for article (PubMed ID: 27492616)

  • 1. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
    Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
    Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: temperance reduces the risk.
    Abiko S; Shimizu Y; Miyamoto S; Ishikawa M; Matsuda K; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Ono K; Sakamoto N
    J Gastroenterol; 2018 Oct; 53(10):1120-1130. PubMed ID: 29423536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between continuous cessation or reduction of drinking alcohol and improvement of multiple dysplastic lesions in patients with esophageal squamous cell carcinoma after endoscopic resection.
    Hori K; Katada C; Okada H; Katagiri A; Matsuo Y; Yokoyama T; Yano T; Suzuki H; Shimizu Y; Furue Y; Nakanishi H; Koike T; Takizawa K; Hirao M; Yoshii T; Yamanouchi T; Kawakubo H; Kobayashi N; Shimoda T; Ochiai A; Ishikawa H; Yokoyama A; Muto M
    Esophagus; 2024 Jan; 21(1):31-40. PubMed ID: 38070099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.
    Wang YK; Chuang YS; Wu TS; Lee KW; Wu CW; Wang HC; Kuo CT; Lee CH; Kuo WR; Chen CH; Wu DC; Wu IC
    Int J Cancer; 2017 Nov; 141(10):1987-1996. PubMed ID: 28758200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the findings of metachronous secondary primary malignancies and the number of Lugol-voiding lesions.
    Katada C; Yokoyama T; Yano T; Oda I; Shimizu Y; Takemura K; Koike T; Takizawa K; Hirao M; Okada H; Nakayama N; Kubota Y; Matsuo Y; Kawakubo H; Ishikawa H; Yokoyama A; Muto M
    Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32052025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
    Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection.
    Urabe Y; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    Endoscopy; 2009 Apr; 41(4):304-9. PubMed ID: 19340732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
    Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
    Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
    Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
    J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
    Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
    Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
    Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
    Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
    Katada C; Muto M; Nakayama M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Yamashita K; Nemoto M; Shibata T; Masaki T; Okamoto M; Koizumi W
    Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck cancer arising after endoscopic mucosal resection for squamous cell carcinoma of the esophagus.
    Shimizu Y; Tsukagoshi H; Fujita M; Hosokawa M; Watanabe A; Kawabori S; Kato M; Sugiyama T; Asaka M
    Endoscopy; 2003 Apr; 35(4):322-6. PubMed ID: 12664389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of esophageal lesions in patients with head and neck squamous cell carcinoma.
    Khoshbaten M; Naderpour M; Mohammadi G; Alipoor SH; Estakhri R; Fazeli Z
    Asian Pac J Cancer Prev; 2010; 11(4):863-5. PubMed ID: 21133592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol consumption, multiple Lugol-voiding lesions, and field cancerization.
    Katada C; Yokoyama T; Yano T; Suzuki H; Furue Y; Yamamoto K; Doyama H; Koike T; Tamaoki M; Kawata N; Hirao M; Kawahara Y; Ogata T; Katagiri A; Yamanouchi T; Kiyokawa H; Kawakubo H; Konno M; Yokoyama A; Ohashi S; Kondo Y; Kishimoto Y; Kano K; Mure K; Hayashi R; Ishikawa H; Yokoyama A; Muto M
    DEN Open; 2024 Apr; 4(1):e261. PubMed ID: 37409321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer.
    Hori K; Okada H; Kawahara Y; Takenaka R; Shimizu S; Ohno Y; Onoda T; Sirakawa Y; Naomoto Y; Yamamoto K
    Am J Gastroenterol; 2011 May; 106(5):858-66. PubMed ID: 21468010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous and metachronous carcinomas of the esophagus and head and neck.
    Natsugoe S; Uchino Y; Kijima F; Shimada M; Shirao K; Kusano C; Baba M; Yoshinaka H; Fukumoto T; Mueller J; Stein HJ; Aikou T
    Dis Esophagus; 1997 Apr; 10(2):134-8. PubMed ID: 9179485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.